179 related articles for article (PubMed ID: 9394170)
1. Liposomal amphotericin B in neonates with invasive candidiasis.
al Arishi H; Frayha HH; Kalloghlian A; al Alaiyan S
Am J Perinatol; 1997 Oct; 14(9):573-6. PubMed ID: 9394170
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B in neonates with invasive candidiasis.
Al Arishi H; Frayha HH; Kalloghlian A; Al Alaiyan S
Am J Perinatol; 1998; 15(11):643-8. PubMed ID: 10064206
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neonatal candidiasis with liposomal amphotericin B(L-AMP-LRC-1): phase II study.
Kotwani RN; Bodhe PV; Kirodian BG; Mehta KP; Ali US; Kshirsagar NA
Indian Pediatr; 2003 Jun; 40(6):545-50. PubMed ID: 12824664
[TBL] [Abstract][Full Text] [Related]
4. [Neonatal candidiasis and liposomal amphotericin B treatment: our experience].
Carrasco Sánchez P; Castillo Montero ML; Bejarano Palma A; López Sanz A; Santano Gallinato M; Sáenz Reguera C; Durán de Vargas L; González-Meneses A
An Esp Pediatr; 1999 Sep; 51(3):273-80. PubMed ID: 10575751
[TBL] [Abstract][Full Text] [Related]
5. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
[TBL] [Abstract][Full Text] [Related]
6. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study.
Arrieta AC; Shea K; Dhar V; Cleary JP; Kukreja S; Morris M; Vargas-Shiraishi OM; Ashouri N; Singh J
Clin Ther; 2010 Feb; 32(2):265-71. PubMed ID: 20206784
[TBL] [Abstract][Full Text] [Related]
7. Liposomal drug delivery system from laboratory to clinic.
Kshirsagar NA; Pandya SK; Kirodian GB; Sanath S
J Postgrad Med; 2005; 51 Suppl 1():S5-15. PubMed ID: 16519249
[TBL] [Abstract][Full Text] [Related]
8. [Candida meningitis, in a premature infant, treated with liposomal amphotericin B and flucytosine].
Houmeau L; Monfort-Gouraud M; Boccara JF; Badoual J
Arch Fr Pediatr; 1993 Mar; 50(3):227-30. PubMed ID: 8338417
[TBL] [Abstract][Full Text] [Related]
9. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
Rieger CT; Dittmer M; Ostermann H
Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
[TBL] [Abstract][Full Text] [Related]
10. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy.
Natarajan G; Lulic-Botica M; Aranda JV
J Perinatol; 2009 Nov; 29(11):738-43. PubMed ID: 19776753
[TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data.
Ng TT; Denning DW
Arch Intern Med; 1995 May; 155(10):1093-8. PubMed ID: 7748054
[TBL] [Abstract][Full Text] [Related]
12. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
Rust DM; Jameson G
Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
[TBL] [Abstract][Full Text] [Related]
13. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases.
López Sastre JB; Coto Cotallo GD; Fernández Colomer B;
Am J Perinatol; 2003 Apr; 20(3):153-63. PubMed ID: 12802715
[TBL] [Abstract][Full Text] [Related]
14. Treatment of neonatal candidiasis with liposomal amphotericin B.
Kapoor D
Indian Pediatr; 2004 May; 41(5):522-3; author reply 523-5. PubMed ID: 15181316
[No Abstract] [Full Text] [Related]
15. What is the current and future status of conventional amphotericin B?
Kleinberg M
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
[TBL] [Abstract][Full Text] [Related]
16. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
17. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates.
Juster-Reicher A; Flidel-Rimon O; Amitay M; Even-Tov S; Shinwell E; Leibovitz E
Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):603-7. PubMed ID: 13680398
[TBL] [Abstract][Full Text] [Related]
18. Liposomal amphotericin B for the treatment of severe fungal infection.
Michaud D
Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
[TBL] [Abstract][Full Text] [Related]
19. Compassionate use protocol initiated for AmBisome.
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):60. PubMed ID: 11363524
[TBL] [Abstract][Full Text] [Related]
20. Antifungal therapy for neonatal candidiasis.
Zaoutis T; Walsh TJ
Curr Opin Infect Dis; 2007 Dec; 20(6):592-7. PubMed ID: 17975409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
